Share on StockTwits
 

Rentokil Initial (LON:RTO)‘s stock had its “neutral” rating reiterated by analysts at Credit Suisse in a research report issued to clients and investors on Friday, American Banking and Market News reports. They currently have a GBX 95 ($1.59) price target on the stock. Credit Suisse’s target price would suggest a potential downside of 24.30% from the company’s current price.

Several other analysts have also recently commented on the stock. Analysts at JPMorgan Chase & Co. reiterated an “underweight” rating on shares of Rentokil Initial in a research note on Wednesday. They now have a GBX 86 ($1.44) price target on the stock. Separately, analysts at Cantor Fitzgerald Europe reiterated a “buy” rating on shares of Rentokil Initial in a research note on Monday. They now have a GBX 140 ($2.35) price target on the stock. Finally, analysts at Jefferies Group raised their price target on shares of Rentokil Initial from GBX 116 ($1.94) to GBX 128 ($2.15) in a research note on Thursday, January 30th. They now have a “hold” rating on the stock. Six research analysts have rated the stock with a sell rating, ten have given a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of GBX 104.79 ($1.76).

Shares of Rentokil Initial (LON:RTO) traded up 0.56% on Friday, hitting GBX 125.50. 2,752,744 shares of the company’s stock traded hands. Rentokil Initial has a one year low of GBX 85.70 and a one year high of GBX 126.60. The stock’s 50-day moving average is GBX 121.4 and its 200-day moving average is GBX 110.6. The company’s market cap is £2.270 billion.

Rentokil Initial plc is the holding company. Revenue is generated from pest control, hygiene, textiles, interior plants, facilities services and parcel delivery.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.